Vaishali Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 259.88 million compared to INR 233.39 million a year ago. Revenue was INR 266.47 million compared to INR 245.09 million a year ago. Net income was INR 32.9 million compared to INR 35.06 million a year ago. Basic earnings per share from continuing operations was INR 3.1 compared to INR 3.32 a year ago. Diluted earnings per share from continuing operations was INR 2.93 compared to INR 3.32 a year ago.